Page last updated: 2024-11-02

pirenzepine and Epilepsy, Temporal Lobe

pirenzepine has been researched along with Epilepsy, Temporal Lobe in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Epilepsy, Temporal Lobe: A localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Swartz, CM1

Other Studies

1 other study available for pirenzepine and Epilepsy, Temporal Lobe

ArticleYear
Misdiagnosis of schizophrenia for a patient with epilepsy.
    Psychiatric services (Washington, D.C.), 2001, Volume: 52, Issue:1

    Topics: Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Diagnostic Errors; Electroencephalog

2001